Equillium EQ
NASDAQ EQ
$1.42 -0.04 (-2.41%)
At close: Nov 11, 2026 · 4:00 PM EST

Equillium (EQ) Net Income Attributable to Noncontrolling Interests (2019 - 2024)

Updated

Analysis

Equillium (EQ) Net Income Attributable to Noncontrolling Interests (2019 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCI Net Income (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 2.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -1.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 10.00 Mn
10 Equillium 163.24 Mn -18.68 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 296,000.00
Mar 31, 2024 283,000.00
Dec 31, 2023 -318,000.00
Sep 30, 2023 118,000.00
Jun 30, 2023 -3.31 Mn
Mar 31, 2023 229,000.00
Dec 31, 2022 -117,000.00
Sep 30, 2022 342,000.00
Dec 31, 2021 -72,000.00
Sep 30, 2021 143,000.00
Mar 31, 2021 42,000.00
Mar 31, 2020 453,000.00
Jun 30, 2019 38,000.00
Mar 31, 2019 44,000.00
API Access

Equillium Net Income Attributable to Noncontrolling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=EQ&period=max&api_key=YOUR_API_KEY